M&A

News

Lawmaker asks FTC to probe Novo/Catalent deal

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give Novo Nordisk control of manufacturing facilities currently operate

R&D

Merger and acquisition visual concept with buildings and jigsaw

Closed and Collaborative: Mergers, acquisitions, and partner...

As we head further into H2, a final look back to the summer’s industry mergers and acquisiti

R&D

Closed and Collaborative: Mergers, acquisitions, and partner...

Summer’s stretch having drawn out a longer return to our round-ups, as the days shorten and we firmly enter autumn, pharmaphorum takes a look back at the industry

News

Organon makes dermatology play with $1.2bn Dermavant buyout

Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, which is also under review by the FDA for atopic dermatitis.

News

Tobacco firm PMI divests Vectura at a loss after backlash

Philip Morris International (PMI) is selling inhaled drug specialist Vectura to Molex Asia Holdings for a fraction of the £1.1 billion ($1.45 billion) it paid for the business three years a

News

Illumina avoids hefty EU fine over Grail merger

The top court in the EU has ruled that the European Commission exceeded its authority in its investigation of the $8 billion merger between Illumina and Grail, albeit too late to halt the f

Lawmaker asks FTC to probe Novo/Catalent deal

Closed and Collaborative: Mergers, acquisitions, and partner...

Closed and Collaborative: Mergers, acquisitions, and partner...

Organon makes dermatology play with $1.2bn Dermavant buyout

Tobacco firm PMI divests Vectura at a loss after backlash

Illumina avoids hefty EU fine over Grail merger

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

M&A

Editor's Picks